December 2021 – Repertoire Magazine
OraSure Technologies, a leading innovator in diagnostic technologies, has partnered with MedPro, a national independent sales organization representing leading medical manufacturers, to bring OraSure’s innovative over-the-counter (OTC) COVID-19 rapid antigen test, InteliSwab, to market.
The strategic partnership leverages MedPro’s experienced nationwide sales team and OraSure’s expertise in infectious disease and molecular sample collection to expand COVID-19 testing to markets outside of healthcare, giving people the power to test anytime, anywhere.
A Solution for Everyone
InteliSwab is a lateral flow in vitro diagnostic antigen test for the detection of COVID-19. As an antigen test, it is designed to detect active infection in individuals, regardless of if they’re showing symptoms.
InteliSwab was designed and developed by OraSure, a leading innovator in diagnostic testing for infectious disease, with the universal need for testing in mind. OraSure created the InteliSwab as a solution for use in markets beyond the traditional acute care or physician office setting.
Designed with both accuracy and ease of use in mind, the result is a user-friendly test that is simple, quick, and non-invasive. The test also boasts impressive accuracy. In a clinical study conducted earlier in 2021, InteliSwab results were compared to highly sensitive molecular FDA Authorized SARS-CoV-2 assays to determine test performance. InteliSwab correctly identified 84% of the positive samples with both low levels and high levels of virus. Additionally, InteliSwab correctly identified 98% of negative samples**.
Smart Science Made Simple
The gentle swab is designed to take samples from only the lower part of the nostril, making it ideal for use with patients in the home health care setting and beyond. The swab is unique in that it’s built into the test device, which means less room for error and a feeling of confidence when running.
In fact, 98% of users found InteliSwab easy to use*.
InteliSwab requires only three key steps**: Swab, Swirl, and See. Users swab their nostrils with the gentle swab, swirl the swab in the tube, and can see their test results in minutes. There are no confusing steps, no batteries needed and no mailing samples to a lab.
The simplicity and ease-of-use of InteliSwab make the test accessible not only for home health and long-term care providers, but for use across industries beyond healthcare, such as business office settings, schools, sports events, and more. Three versions of this innovative test are available to suit different needs:
- InteliSwab™ COVID-19 Rapid Test
- InteliSwab™ COVID-19 Rapid Test Rx
- InteliSwab™ COVID-19 Rapid Test Pro
The test has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) and is available OTC for non-prescription home use with self-collected nasal swabs.
Visit www.InteliSwab.com to learn more.
*Per a usability study (see pg. 13) https://inteliswab.com/wp-content/uploads/2021/06/05a-EUA210378_OraSure.OTC_.IFU_.-06-04-2021.pdf
**Please refer to the instructions for use for more information.